# US 2023/0057339 A1 · Systems and methods for characterizing locations of target analytes in multi-dimensional space

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0057339 A1
- Document ID: US20230057339A1
- Status: Published application
- Kind: A1
- Application number: 17/895,633
- Filed: 2022-08-25
- Published: 2023-02-23
- Earliest claimed: 2021-08-20
- Assignees: 13.8, Inc.
- Applicants: 13.8, Inc.
- Inventors: Stephen P.A. Fodor; Hei Mun Christina Fan; Anaram Shahravan; Christina Chang; Jay Levine
- Web page: https://patentgrep.com/patent/US20230057339A1

## CPC

- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6841: In situ hybridisation
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6853: using modified primers or templates
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2525/179: incorporating arbitrary or random nucleotide sequences
- C12Q 2563/149: Particles, e.g. beads
- C12Q 2565/514: characterised by the use of the arrayed oligonucleotides as identifier tags, e.g. universal addressable array, anti-tag or tag complement array
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Systems, methods, and compositions for generating a high-resolution spatial map of a distribution of targets of a sample are described. Processes for generating the spatial map can include: receiving the sample at a substrate having a distribution of functionalized particles, each having a stochastic barcode sequence paired with a position on the substrate; promoting interactions between the distribution of targets of the sample and the distribution of functionalized particles upon transmitting heat to a surface of the substrate opposite the distribution of functionalized particles; applying a set of reactions to the sample at the substrate, obtaining a set of sequences of a population of molecules generated from the set of reactions, the set of sequences associated with the distribution of targets labeled using the stochastic barcode sequences of the distribution of functionalized particles, and returning a set of positions of the distribution of targets upon processing the set of sequences.

## Claims

### Claim 1

A method comprising:
generating a spatial map of a distribution of targets of a tissue sample, wherein upon generating the spatial map by a set of processes, the spatial map has a resolution of greater than one target mapped per 100 um2, for each of a set of 20,000 targets, and wherein the set of processes comprises:
receiving the tissue sample at a substrate comprising a distribution of functionalized particles arranged in a random close packed configuration, each of the distribution of functionalized particles comprising a stochastic barcode sequence paired with a position on the substrate,
promoting interactions between the distribution of targets of the tissue sample and the distribution of functionalized particles,
applying a set of reactions to the tissue sample at the substrate,
obtaining a set of sequences of a population of molecules generated from the set of reactions, the set of sequences associated with the distribution of targets labeled using the stochastic barcode sequences of the distribution of functionalized particles, and
returning a set of positions of the distribution of targets upon processing the set of sequences.

### Claim 2 (depends on 1)

The method of claim 1, wherein the distribution of functionalized particles comprises functionalized particles each having a diameter of less than 5 micrometers, and wherein the distribution of functionalized particles is arranged in a close-packed configuration at the substrate.

### Claim 3 (depends on 1)

The method of claim 1, wherein receiving the tissue sample comprises receiving a non-permeabilized tissue sample.

### Claim 4 (depends on 3)

The method of claim 3, wherein the spatial map is characterized by a signal-to-noise ratio (SNR) greater than 100,000, when the SNR is determined by:
identifying a gene with a known expression profile across regions of the tissue sample, wherein the set of 20,000 targets comprises the gene,
quantifying expression of the gene across the sample based upon the set of positions of the distribution of targets,
determining a signal value from expression of the gene in regions of the tissue sample that should express the gene, based upon the known expression profile,
determining a noise value from expression of the gene in regions of the tissue sample that should not express the gene, based upon the known expression profile, and determining the SNR from the signal value and the noise value.

### Claim 5 (depends on 4)

The method of claim 4, wherein the tissue sample comprises hippocampus tissue, and wherein the gene comprises one of hippocalcin (hpca) gene and transthyretin (ttr) gene.

### Claim 6 (depends on 3)

The method of claim 3, wherein the spatial map is characterized by a false positive rate of less than 10% positive copies of targets beyond 10 micrometers from originating positions of said targets in the tissue sample.

### Claim 7 (depends on 1)

The method of claim 1, wherein the tissue sample comprises at least one of: nervous system tissue, integumentary system tissue, musculoskeletal system tissue, digestive system tissue, and endocrine system tissue.

### Claim 8 (depends on 1)

The method of claim 1, wherein the tissue sample comprises a cell-seeded scaffold.

### Claim 9 (depends on 1)

The method of claim 1, wherein receiving the tissue sample comprises providing a support structure for the substrate, the support structure comprising:
an opening,
a flexible film coupled to a first side of the support structure about the opening and supporting the substrate within the opening, and
a protective covering coupled to a second side of the support structure and opposing the flexible film at the opening.

### Claim 10 (depends on 9)

The method of claim 9, wherein receiving the tissue sample comprises positioning a frozen tissue slice at the substrate post-removal of the protective covering from the support structure, and wherein promoting interactions between the distribution of targets of the tissue sample and the distribution of functionalized particles comprises transmitting heat to the frozen tissue slice through the flexible film.

### Claim 11 (depends on 10)

The method of claim 10, wherein, during application of the set of reactions to the tissue sample, the flexible film is deformed to displace the substrate into a process container for a subset of the set of reactions.

### Claim 12 (depends on 1)

The method of claim 1, further comprising freezing the tissue sample for a duration of time between:
a) promoting interactions between the distribution of targets of the tissue sample and the distribution of functionalized particles, and
b) applying the set of reactions to the tissue sample at the substrate.

### Claim 13 (depends on 1)

The method of claim 1, wherein the set of reactions comprises a first subset of reactions performed at the substrate, the first subset of reactions comprising:
a hybridization reaction between target material of the tissue sample and capture segments of the distribution of functionalized particles;
a reverse transcription operation performed upon outputs of the hybridization operation; and
a template switching operation performed upon outputs of the reverse transcription operation.

### Claim 14 (depends on 13)

The method of claim 13, wherein the set of reactions further comprises a second subset of reactions performed upon clearing the tissue sample from the substrate and resuspending the distribution of functionalized particles within a process container, the second subset of reactions comprising:
a second strand synthesis operation;
a cDNA amplification operation performed with outputs of the second strand synthesis operation;
a tagmentation operation performed with outputs of the cDNA amplification operation; and
an indexing PCR operation performed with outputs of the tagmentation operation.

### Claim 15 (depends on 1)

The method of claim 1, wherein the distribution of functionalized particles comprises particles separated by less than 50 picometers from adjacent particles of the distribution of functionalized particles.

### Claim 16

A method comprising:
generating a spatial map of a distribution of targets of a tissue sample, wherein upon generating the spatial map by a set of processes, the spatial map is characterized by a signal-to-noise ratio (SNR) greater than 100,000, and wherein the set of processes comprises:
receiving the tissue sample at a substrate comprising a distribution of functionalized particles arranged in a random close packed configuration, each of the distribution of functionalized particles comprising a stochastic barcode sequence paired with a position on the substrate,
applying a set of reactions to the tissue sample at the substrate,
obtaining a set of sequences of a population of molecules generated from the set of reactions, the set of sequences associated with the distribution of targets labeled using the stochastic barcode sequences of the distribution of functionalized particles, returning a set of positions of the distribution of targets upon processing the set of sequences,
identifying a gene with a known expression profile across regions of the tissue sample,
quantifying expression of the gene across the sample based upon the set of positions of the distribution of targets,
determining a signal value from expression of the gene in regions of the tissue sample that should express the gene, based upon the known expression profile,
determining a noise value from expression of the gene in regions of the tissue sample that should not express the gene, based upon the known expression profile, and
determining the SNR from the signal value and the noise value.

### Claim 17 (depends on 16)

The method of claim 16, wherein the SNR is greater than 1,000,000.

### Claim 18 (depends on 16)

The method of claim 16, wherein receiving the tissue sample comprises receiving a non-permeabilized tissue sample.

### Claim 19 (depends on 16)

The method of claim 16, further comprising freezing the tissue sample for a duration of time between:
a) receiving the tissue sample at the substrate, and
b) applying the set of reactions to the tissue sample at the substrate.

### Claim 20 (depends on 16)

The method of claim 16, wherein receiving the tissue sample comprises providing a support structure for the substrate, the support structure comprising:
an opening, and
a flexible film coupled to a first side of the support structure about the opening and supporting the substrate within the opening.

### Claim 21 (depends on 20)

The method of claim 20, wherein receiving the tissue sample comprises transmitting heat to the frozen tissue slice through the flexible film, and
wherein, during application of the set of reactions to the tissue sample, the flexible film is deformed to displace the substrate into a process container for a subset of the set of reactions.

### Claim 22

A method comprising:
generating a spatial map of a distribution of targets of a tissue sample, wherein upon generating the spatial map by a set of processes, the spatial map is characterized by a false positive rate of less than 10% positive copies of targets beyond 10 micrometers from originating positions of said targets in the tissue sample, and wherein the set of processes comprises:
receiving the tissue sample at a substrate comprising a distribution of functionalized particles arranged in a random close packed configuration, each of the distribution of functionalized particles comprising a stochastic barcode sequence paired with a position on the substrate,
applying a set of reactions to the tissue sample at the substrate,
obtaining a set of sequences of a population of molecules generated from the set of reactions, the set of sequences associated with the distribution of targets labeled using the stochastic barcode sequences of the distribution of functionalized particles,
returning a set of positions of the distribution of targets upon processing the set of sequences,
identifying a gene with a known expression profile across regions of the tissue sample, and
determining the false positive rate upon quantifying expression of the gene across the sample based upon the set of positions of the distribution of targets.
